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LETTERS
Mumps Virus–
associated
Hemophagocytic
Syndrome
To the Editor: Virus-associated
hemophagocytic syndrome (VAHS) is
a fulminant disorder associated with
systemic viral infection and is charac-
terized pathologically by the prolifer-
ation of hemophagocytic histiocytes
in the lymphoreticular tissues. Here
we report a case of mumps VAHS fol-
lowing parotitis and pancreatitis.
A 39-year-old, previously healthy
woman sought treatment for abdomi-
nal pain on June 14, 2002. On physical
examination, her bilateral parotid
glands were swollen, and her left
upper quadrant was tender. Laboratory
studies showed a leukocyte count of
4,640/mm3, a hemoglobin concentra-
tion of 13.9 g/dL, and a platelet count
of 19.1 × 104/mm3. The level of amy-
lase was elevated in her blood (1,613
IU/L; normal 50–160 IU/L) and urine
(12,940 IU/L; normal 200–1,100
IU/L). Her level of pancreatic
enzymes was also elevated: lipase
level was 194 IU/L (normal 7–60
IU/L) and phospholipase A2 level was
1,340 ng/dL (normal 130–400 ng/dL).
Parotitis and acute pancreatitis due to
a mumps virus infection were diag-
nosed. After supportive therapy,  the
laboratory abnormalities improved.
On July 1, the patient’s tempera-
ture suddenly rose to 39°C. At that
time, pancytopenia was evident, with
a leukocyte count of 2,350/mm3, a
hemoglobin concentration of 10.9
g/dL, and a platelet count of 9.1 ×
104/mm3. Laboratory studies showed
an elevation of lactic dehydrogenase
(1,403 IU/L; normal 180–460 IU/L),
ferritin (12,727.0 ng/mL; normal
4.0–64.2 ng/mL), and soluble inter-
leukin-2 receptors (1,660 U/mL; nor-
mal 145–519 U/mL). Hypercyto-
kinemia was also shown, with an
interleukin-6 of 12.7 pg/mL (normal
<3.1 pg/mL). Her bone marrow was
normocellular, and an increased num-
ber of histiocytes with hemophagocy-
tosis was found. Extensive cultures
and serologic studies for microbial
and viral infections were all negative,
whereas tests for immunoglobulin G
and immunoglobulin M antibodies
against the mumps virus were
both positive. Mumps VAHS was
diagnosed. Treatment with corticos-
teroids led to a complete remission of
symptoms. 
VAHS was initially reported by
Risdall et al. in 1979 (1). Although the
precise pathogenesis of VAHS
remains unknown, current hypotheses
focus on the roles played by activating
cytokines. VAHS has been reported in
connection with a variety of viruses:
adenovirus, cytomegalovirus, dengue,
Epstein-Barr, hepatitis A, hepatitis B,
hepatitis C, herpes simplex, HIV,
human herpesvirus 6, human her-
pesvirus 8, influenza A(antigenic type
H1N1), measles, parainfluenza type
III, parvovirus B 19, rubella, and vari-
cella-zoster (2). This report is the first
of a VAHS case associated with a
mumps virus infection. The clinical
course of VAHS is highly variable,
and in some cases, especially in
Epstein-Barr virus infection, VAHS is
a dramatic illness with a potentially
fatal outcome (2). This case implies
that mumps VAHS may have a posi-
tive prognosis.
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Imported Cutaneous
Diphtheria,
Germany, 1997–2003
To the Editor: The March 2004
report by de Benoist et al. on the inci-
dence of imported cutaneous diphthe-
ria in the United Kingdom (1)
prompted us to describe the situation
of cutaneous diphtheria in Germany
and to analyze the cases reported to
the German Consiliary Laboratory on
Diphtheria since its establishment at
our institute in 1997. The laboratory
provides advisory and diagnostic
services mainly to microbiologic lab-
oratories throughout Germany. 
From 1997 to 2003, 6 cases of
cutaneous infections caused by toxi-
genic  Corynebacterium diphtheriae
were documented (Table). None of
these was accompanied by secondary
diphtheria infection. Toxigenicity
was determined by both dtx poly-
merase chain reaction and Elek test
(2). As in the United Kingdom, all
cases for which clinical information
was available (N = 5) were imported.
Three were found in tourists who had
traveled to tropical countries: a
20-year-old diver had injured her heel
after stepping on coral in Thailand; a
60-year-old tourist had a chronic
ulcer develop in the thigh after a trip
to Indonesia (no history of an insect
bite); and a 39-year-old traveler to
Kenya returned with a purulent ear
infection with no memory of trauma
or insect bite. The remaining import-
ed  C. diphtheriae skin infections
were reported in 2 Angolan children,
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